PubRank

Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines-Stroke registry.

PubWeight™: 0.91‹?›

🔗 View Article (PMID 25642650)

Published in JAMA Neurol on April 01, 2015

Authors

Jose G Romano1, Eric E Smith2, Li Liang3, Hannah Gardener1, Sara Camp4, Laura Shuey4, Alison Cook4, Iszet Campo-Bustillo1, Pooja Khatri5, Deepak L Bhatt6, Gregg C Fonarow7, Ralph L Sacco1, Lee H Schwamm8

Author Affiliations

1: Department of Neurology, University of Miami Miller School of Medicine, Miami, Florida.
2: Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
3: Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
4: American Heart Association, Dallas, Texas.
5: Department of Neurology, University of Cincinnati, Cincinnati, Ohio.
6: Department of Medicine, Brigham and Women's Hospital Heart & Vascular Center/Harvard Medical School, Boston, Massachusetts.
7: Department of Medicine, University of California, Los Angeles.
8: Department of Neurology, Massachusetts General Hospital/Harvard Medical School, Boston.

Associated clinical trials:

Mild and Rapidly Improving Stroke Study (MaRISS) | NCT02072681

Articles citing this ↘

Gender and Time to Arrival among Ischemic Stroke Patients in the Greater Cincinnati/Northern Kentucky Stroke Study. J Stroke Cerebrovasc Dis (2015) 0.80

Blood transcriptome changes after stroke in an African American population. Ann Clin Transl Neurol (2016) 0.80

Increasing atrial fibrillation prevalence in acute ischemic stroke and TIA. Neurology (2016) 0.77

Vectorized nanodelivery systems for ischemic stroke: a concept and a need. J Nanobiotechnology (2017) 0.75

Renal Subcapsular Hematoma after Intravenous Thrombolysis in a Patient with Acute Cerebral Infarction. Neurointervention (2016) 0.75

The American Heart Association's Get With the Guidelines (GWTG)-Stroke development and impact on stroke care. Stroke Vasc Neurol (2017) 0.75

Articles by these authors ⇆

Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative. JAMA (2014) 2.43

Effectiveness of Remote Patient Monitoring After Discharge of Hospitalized Patients With Heart Failure: The Better Effectiveness After Transition-Heart Failure (BEAT-HF) Randomized Clinical Trial. JAMA Intern Med (2016) 1.77

Are the Current Risks of Asymptomatic Carotid Stenosis Exaggerated?: Further Evidence Supporting the CREST 2 Trial. JAMA Neurol (2015) 0.83

Outcomes of medicare beneficiaries with heart failure and atrial fibrillation. JACC Heart Fail (2014) 0.82

Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin. Am J Cardiol (2015) 0.79

A Mediterranean-style diet and left ventricular mass (from the Northern Manhattan Study). Am J Cardiol (2014) 0.77

Defining mild stroke: outcomes analysis of treated and untreated mild stroke patients. J Stroke Cerebrovasc Dis (2015) 0.75

Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development. Alzheimers Dement (N Y) (2016) 0.75

Antiplatelet patterns and outcomes in patients with atrial fibrillation not prescribed an anticoagulant after stroke. Int J Cardiol (2020) 0.75

Absence of Oral Anticoagulation and Subsequent Outcomes Among Outpatients with Atrial Fibrillation. Am J Med (2016) 0.75

New insights into cerebral small vessel disease and vascular cognitive impairment from MRI. Curr Opin Neurol (2017) 0.75

Determining the impact of psychosis on rates of false-positive and false-negative diagnosis in Alzheimer's disease. Alzheimers Dement (N Y) (2017) 0.75

Association of Atrial Fibrillation Clinical Phenotypes with Treatment Patterns and Outcomes: A Multicenter Registry Study. JAMA Cardiol (2017) 0.75